Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Oncology|September 19, 2022
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter studyKohichi Takada, Tomohiro Kubo, Junko Kikuchi, et al.Cancer Science|January 26, 2024
Patient survey on cancer genomic medicine in Japan under the national health insurance systemHidenori Kage, Nana Akiyama, Hyangri Chang, et al.Japanese Journal of Clinical Oncology|February 3, 2021
Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, JapanJunko Kikuchi, Yoshihito Ohhara, Kohichi Takada, et al.Cancer Science|May 20, 2023
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancersKanako Hagio, Junko Kikuchi, Kohichi Takada, et al.Rheumatology (Oxford, England)|April 3, 2025
Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathiesShogo Komaki, Akatsuki Kubota, Asuka Kitamura, et al.Chemical & Pharmaceutical Bulletin|October 22, 2020
Absolute Purity Determination of a Hygroscopic Substance, Indocyanine Green, Using Quantitative NMR (qNMR)Nahoko Uchiyama, Junko Hosoe, Naoki Sugimoto, et al.Chemical & Pharmaceutical Bulletin|April 15, 2021
Purity Determination of Cyclophosphamide Hydrate by Quantitative <sup>31</sup>P-NMR and Method ValidationNahoko Uchiyama, Junko Hosoe, Naoki Sugimoto, et al.Chemical & Pharmaceutical Bulletin|October 12, 2022
Quantitative <sup>31</sup>P-NMR for Purity Determination of Sofosbuvir and Method ValidationNahoko Uchiyama, Kohei Kiyota, Junko Hosoe, et al.Pageof 5